Forms & Information

Ask An Expert

Ipilimumab among treatment advances for metastatic melanoma

Many different systemic therapies have been tested for melanoma over the past 50 years, with generally disappointing results. The phase 3 study of ipilimumab was the first to show a survival benefit for any medical therapy in melanoma. – By Brendan Curti, M.D., medical director, Providence Biotherapy Program, Providence Melanoma Program

Forms Instructions

Bringing out the big guns to kill cancer

Technology opens new doors for combining radiation and immunotherapy.

Prostate cancer research gets a boost

Prostate cancer, once it spreads to lymph nodes and bones, generally is not curable. But basic and clinical researchers at Providence are working on this challenge.

Clinical publications

Learn clinical best practices and the latest advances in techniques, treatments, technology and research. Newsletter articles are reviewed by physician editorial boards and are written by Providence specialists in brain, spine, cancer, orthopedics, and heart and vascular medicine.

Proprietary Health Article

Advances in prostate cancer immunotherapy at Providence

As knowledge about the immune system explodes, so does the potential of innovative treatments. – By Brendan Curti, M.D., medical director, Providence Genitourinary Oncology Research

Breast cancer chemoprevention in the spotlight again

After a tentative start, chemopreventive therapies might return to the forefront.  A recent international study reports promising results. – By Ali Conlin, M.D., medical oncologist

Early-phase clinical trials open new opportunities

Providence's involvement with the International Immuno-Oncology Network, along with other early-phase studies, is broadening treatment options for patients with advanced cancers. – By Rachel E. Sanborn, M.D., co-medical director, Providence Thoracic Oncology Program

New system therapies emerge for liver cancer

A study at Providence Cancer Center builds on the success of sorafenib. – By Todd S. Crocenzi, medical oncologist and researcher

Prostate cancer and PSA: Should your patient get screened?

Oncologist and researcher Brendan Curti, M.D., discusses the benefits and limitations of the prostate-specific antigen test – and which patient groups can benefit from annual screening.

Studying apricoxib with erlotinib for lung cancer

A trial testing apricoxib with erlotinib showed longer survival in younger patients with metastatic lung cancer, but failed to meet its goal. – By Rachel E. Sanborn, M.D., medical oncologist

Studying statin chemoprevention in colon cancer patients

A clinical trial examines whether statins will inhibit a recurrence in patients with resected stage I or II colorectal cancer. – By Anupama Kurup, M.D., medical oncologist

Colorectal cancer risks: tobacco, obesity and inactivity

Once again, tobacco use is firmly established as a cause of cancer, this time, colorectal cancer. – By Todd S. Crocenzi, medical oncologist and researcher

Can an exercise program ease chemotherapy fatigue?

A study examines the effects of exercise for cancer patients starting chemotherapy. – By Anupama Kurup, M.D., medical oncologist

Recommended Resource

American Cancer Society

American Cancer Society’s home page with links to all types of cancer, symptoms, treatment options, statistics trials and ways to contribute. 

American Cancer Society: Cancer staging

American Cancer Society’s description and explanation of staging cancer. Staging is the process of finding out how much cancer there is in the body and where it is located. It is how the doctor learns the stage of a person's cancer. Doctors use this information to plan treatment and to help find out a person's outlook (prognosis). 

National Cancer Institute

National Cancer Institute home page with links to all cancer topics, clinical trial information, statistics, research and treatment information.

National Cancer Institute Physician Data Query

The National Cancer Institute’s comprehensive cancer database contains summaries on a wide range of cancer topics, a registry of more than 8,000 open and 19,000 closed cancer clinical trials from around the world and a directory of professionals who provide genetics services.

National Institutes of Health Office of Rare Diseases Research: Research and clinical trials

Links to Federal and non-federal information about research into rare diseases including ORDR-supported research. When you enter most of the Web sites listed below, you will leave the ORDR Web site. Please return to find more information about research resources, scientific conferences, genetics information and services, and other related information.

CancerCare.org

Cancer Care is a national nonprofit that provides free, professional support services for anyone affected by cancer.

ClinicalTrials.gov Frequently Asked Questions

Choosing to participate in a clinical trial is an important personal decision. The following frequently asked questions provide detailed information about clinical trials. In addition, it is often helpful to talk to a physician, family members, or friends about deciding to join a trial. After identifying some trial options, the next step is to contact the study research staff and ask questions about specific trials.

ClinicalTrials.gov

ClinicalTrials.gov is a registry of federally and privately supported clinical trials conducted in the United States and around the world. ClinicalTrials.gov gives you information about a trial's purpose, who may participate, locations, and phone numbers for more details. This information should be used in conjunction with advice from health care professionals.

Cancer.net (AKA: People Living with Cancer)

Oncologist-approved cancer information from the American Society of Clinical Oncology